Intrinsic Value of S&P & Nasdaq Contact Us

Homology Medicines, Inc. FIXX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
63/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.70
+188.9%

Stock Statistics — FIXX

Homology Medicines, Inc. (FIXX) has a market capitalization of $3.02M and trades at $0.93. The 52-week range is 0.9-26.64.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 0.4, Earnings Per Share (EPS) of $2.42.

The stock has a beta of -0.11, operates in the Healthcare sector.

Trading Data
Current Price$0.93
52-Week Range0.9-26.64
Volume401.47K
Avg Volume (30D)29.54K
Market Cap$3.02M
Beta (1Y)-0.11
Company
IPO Date2018-03-28
Employees7
CEOPaul Alloway
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS4380831077
CUSIP438083107
Income (Latest Year)
EBITDA$16.9M
Operating Income$16.9M
Net Income$29.82M
EPS$2.42
EPS Diluted$2.42
Shares Outstanding$12.3M
Balance Sheet (Latest Year)
Total Assets$61.78M
Current Assets$55.05M
Cash & ST Investments$48.3M
Total Liabilities$19.76M
Total Debt$11.18M
Net Debt$-37.12M
Total Equity$42.01M
Debt / Equity0.27
Valuation Ratios
P/E Ratio0.4
P/B Ratio0.07
EV/EBITDA (approx)0.2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message